The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Genaera Corporation

Genaera Corporation
Nasdaq: GENR
Change
symbol:
     
 PROFILE
Development-stage Genaera Corporation (formerly Magainin Pharmaceuticals) is working on treatments for infection, cancer, respiratory diseases, and obesity. Its efforts focus on host-defense drug discovery, which attempts to isolate therapeutic compounds from animal defense systems and genetic research. Among the drug candidates the company is developing is squalamine, a potential therapy for non-small cell lung cancer and ovarian cancer. It is also developing produlestan, a possible treatment for obesity. Genaera is working with the Ludwig Institute for Cancer Research to develop certain genes and proteins the pair have uncovered through joint research and development.

 COMPETITION
Chiron Corporation (CHIR)
Genentech, Inc. (DNA)
Genzyme Molecular Oncology (GZMO)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 0.10
1-Yr. Sales Growth: (50.0)%
Employees: 46
Revenue per employee: $2,173.91

 KEY PEOPLE
• Roy C. Levitt
    CEO
• Christopher P. Schnittker
    CFO

 CONTACT INFO
5110 Campus Dr.
Plymouth Meeting, PA 19462
US
Phone: 610-941-4020
Fax: 610-941-5399
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001